Unigene Announces Key Appointments as Biotechnologies Strategic Business Unit Continues to Grow in 2012

- Gregory T. Mayes, Esq. Promoted to Chief Business Officer - - Jane Pepper, M.B.A, Ph.D., Formerly of Novartis Pharmaceuticals, Appointed to Senior Director, Business Development - BOONTON, N.J., Feb. 8, 2012 /PRNewswire/ --  Unigene Laboratories, Inc. (OTCBB: UGNE), today announced the expansion of its Biotechnologies strategic business unit (SBU) with the promotion of Gregory T. Mayes, Esq. to the position of Chief Business Officer and the appointment of Jane Pepper, M.B.A, Ph.D. to Senior ...continued UGNE  Drugs stock osteoporosis

URL: http://www.investorpoint.com/news/OTCBULLB/48225762/